Presented By: Kate Baldwin Liz Thayer ComDis 624 …people.umass.edu/mva/pdf/ComDis 624 Student...
Transcript of Presented By: Kate Baldwin Liz Thayer ComDis 624 …people.umass.edu/mva/pdf/ComDis 624 Student...
Hemifacial SpasmHemifacial SpasmPresented By:Presented By:Kate BaldwinKate Baldwin
Liz ThayerLiz ThayerMay 15May 15thth, 2008, 2008
ComDisComDis 624624Motor Speech DisordersMotor Speech Disorders
What is Hemifacial Spasm?What is Hemifacial Spasm?
HFS is a hyperkinetic movement disorder HFS is a hyperkinetic movement disorder characterized by involuntary spasmscharacterized by involuntary spasms
HFS affects the muscles innervated by the HFS affects the muscles innervated by the facial nervefacial nerve
The spasms are uncontrollable and may be The spasms are uncontrollable and may be clonic (brief) or tonic (continuous) in clonic (brief) or tonic (continuous) in naturenature
What is the Cause of Hemifacial What is the Cause of Hemifacial Spasm?Spasm?
The most common cause is contact The most common cause is contact between a blood vessel and the root exit between a blood vessel and the root exit zone of the facial nerve zone of the facial nerve
An artery often causes compression on the An artery often causes compression on the facial nerve if it is dilated or hardened facial nerve if it is dilated or hardened
The arteries most commonly involved are The arteries most commonly involved are the AICA, PICA, and vertebral arterythe AICA, PICA, and vertebral artery
TuncTunc et al. (2008)et al. (2008)
Causes Causes ctdctd..
A limited number of cases of HFS have A limited number of cases of HFS have been attributed to tumors, demyelinating been attributed to tumors, demyelinating disorders, or infections (Park et al.,2008) disorders, or infections (Park et al.,2008)
A rare study cited by A rare study cited by TuncTunc et al. (2008) et al. (2008) found a number of patients with HFS found a number of patients with HFS without a localizable lesion without a localizable lesion
Clinical Presentation of HFSClinical Presentation of HFS
A typical spasmA typical spasm……begins with involuntary twitching of the begins with involuntary twitching of the orbicularisorbicularis oculioculi
is initially clonic in nature and then a tonic phase takes is initially clonic in nature and then a tonic phase takes place, in which the ipsilateral eye is forced closedplace, in which the ipsilateral eye is forced closed
gradually increases in intensity and begins to affect other gradually increases in intensity and begins to affect other muscles on the same side of the facemuscles on the same side of the face
““Emotional stress, voluntary contraction of any facial muscles, aEmotional stress, voluntary contraction of any facial muscles, and fatigue nd fatigue make it worse. The severity of the spasm fluctuates but tends gemake it worse. The severity of the spasm fluctuates but tends generally to nerally to worsen with timeworsen with time”” ((SauvainSauvain et al., 2001)et al., 2001)
SauvainSauvain et al. (2001) Tan et al. (2002) et al. (2001) Tan et al. (2002)
How do You Diagnose How do You Diagnose Hemifacial Spasm?Hemifacial Spasm?
Use of MRIUse of MRI
Neurological featuresNeurological features
Clinical featuresClinical features
Differential diagnosisDifferential diagnosis
TreatmentsTreatments
Current treatmentsCurrent treatments
BotulinumBotulinum Toxin injectionsToxin injections
Microvascular nerve Microvascular nerve decompressiondecompression
Oral medicationsOral medications
BotoxBotox
Causes temporary weakness of musclesCauses temporary weakness of muscles
Effects last approximately 3Effects last approximately 3--4 months 4 months need to need to continuously receive injectionscontinuously receive injections
Some argue that Some argue that BotoxBotox can be used over a long can be used over a long period of time without major side effectsperiod of time without major side effects
Site of injections should reflect the individualSite of injections should reflect the individual’’s s needs however there are common injection sitesneeds however there are common injection sites
Ward et al. (2006), Tan eWard et al. (2006), Tan et al. (2002) t al. (2002)
Microvascular Nerve Microvascular Nerve DecompressionDecompression
Can provide a permanent solutionCan provide a permanent solution
Involves placing a barrier in between Involves placing a barrier in between CN VII and the arteryCN VII and the artery
Success rate of 85%Success rate of 85%--97%97%
FreiFrei et al. (2006), Park et al. (2008), et al. (2006), Park et al. (2008), HeuserHeuser et al. (2007)et al. (2007)
Microvascular Nerve Microvascular Nerve DecompressionDecompression
SauvainSauvain et al. (2001)et al. (2001)
Case StudyCase StudyK.T.K.T.
5050--yearyear--old right handed old right handed malemale
Native Cantonese Native Cantonese speakerspeaker
K.T. Background InformationK.T. Background Information
SelfSelf--referred to Center for Language, Speech, referred to Center for Language, Speech, and Hearing in March of 2006 for accent and Hearing in March of 2006 for accent reductionreduction
LeftLeft--sided sided hemifacialhemifacial spasm and paralysis spasm and paralysis observedobserved
Paralysis secondary to Paralysis secondary to BotoxBotox injections the injections the client was receiving to treat the client was receiving to treat the hemifacialhemifacialspasm = Mild Flaccid spasm = Mild Flaccid DysarthriaDysarthria!!
Microvascular nerve decompression in Microvascular nerve decompression in October of 2007October of 2007
Measures of AssessmentMeasures of Assessment
2 months pre2 months pre--op., 1 week postop., 1 week post--op., 1 month op., 1 month postpost--op, 5 months postop, 5 months post--op. op.
Oral PeripheralOral Peripheral--Neurological Motor Speech Neurological Motor Speech Examination (Mayo Clinic Procedures)Examination (Mayo Clinic Procedures)
Photo Articulation Test, 3rd EditionPhoto Articulation Test, 3rd Edition ((PATPAT--3)3)
Assessment of Intelligibility of Assessment of Intelligibility of DysarthricDysarthricSpeechSpeech ((AIDSAIDS))
Oral PeripheralOral Peripheral--Neurological Neurological Motor Speech ExaminationMotor Speech Examination
Facial symmetry improvementFacial symmetry improvement
Decreased MPT Decreased MPT musculoskeletal tensionmusculoskeletal tension
Most salient improvements:Most salient improvements:
Smile on commandSmile on command
Lip roundingLip rounding
Assessments of SpeechAssessments of Speech
PATPAT--33 AccuracyAccuracy
AIDS AIDS IntelligibilityIntelligibility
AccuracyAccuracy vs. vs. IntelligibilityIntelligibility??
Photo Articulation Test, 3rd Photo Articulation Test, 3rd EditionEdition ((PATPAT--3)3)
Measured Measured accuracyaccuracy of Cof C’’s and Vs and V’’s in wordss in words
Frequency of errors decreased over timeFrequency of errors decreased over time
ALL errors made can be attributed to ESLALL errors made can be attributed to ESL
For example:For example:
[u] for [[u] for [ʊʊ], distortion of [l], and devoicing ], distortion of [l], and devoicing of [z]of [z]
TreatmentTreatment vs. vs. BotoxBotox/Surgery??/Surgery??
Assessment of Intelligibility of Assessment of Intelligibility of DysarthricDysarthric SpeechSpeech ((AIDSAIDS))
Measured Measured intelligibilityintelligibility in words in words and sentencesand sentences
Improvement over time Improvement over time 70%70% 100% (WOW!)100% (WOW!)
Sentence level intelligibility aided Sentence level intelligibility aided by contextby context
Treatment vs. Treatment vs. BotoxBotox/Surgery/Surgery????
DiscussionDiscussion
Why is K.T a unique case?Why is K.T a unique case?
ESL vs. Mild Flaccid ESL vs. Mild Flaccid DysarthriaDysarthria
Accuracy vs. IntelligibilityAccuracy vs. Intelligibility
Speech Speech TxTx vs. vs. BotoxBotox vs. Surgery vs. Surgery
Prognosis Prognosis Good!Good!
ReferencesReferencesBarton, J. (2007). Barton, J. (2007). BotulinumBotulinum neurotoxin type A free of neurotoxin type A free of complexingcomplexing proteins (XEOMIN) in focal proteins (XEOMIN) in focal dystoniadystonia. . Drugs, 67,Drugs, 67, 669669--683.683.BentsianovBentsianov, B., , B., ZalvanZalvan, C., Blitzer, A. (2004). , C., Blitzer, A. (2004). NoncosmeticNoncosmetic uses of uses of botulinumbotulinum toxin.toxin. Clinics in Clinics in Dermatology, 22,Dermatology, 22, 8282--88.88.CancelliCancelli, I., , I., CecottiCecotti, L., , L., ValentinisValentinis, L., , L., BergonziBergonzi, P., Gigli, G. (2005). , P., Gigli, G. (2005). Hemifacial spasm due to a Hemifacial spasm due to a tentorialtentorial paramedianparamedian meningiomameningioma: A case report.: A case report. Neurological Sciences, 26,Neurological Sciences, 26, 4646--49.49.CarruthersCarruthers, J., , J., CarruthersCarruthers, A. (2004). , A. (2004). BotoxBotox: Beyond wrinkles.: Beyond wrinkles. Clinics in Dermatology, 22,Clinics in Dermatology, 22, 8989--93.93.DefazioDefazio, G., , G., AbbruzzeseAbbruzzese, G., , G., GirlandaGirlanda, P., Vacca, L., , P., Vacca, L., CurraCurra, A., De , A., De SalviaSalvia, R., , R., MarcheseMarchese, R., , R., RaineriRaineri, R., , R., RoselliRoselli, F., , F., LivreaLivrea, P., , P., BerardelliBerardelli, A. (2002). , A. (2002). BotulinumBotulinum toxin A treatment for toxin A treatment for primary primary hemifacialhemifacial spasm. spasm. Arch Neurology, 59Arch Neurology, 59, 418, 418--420.420.EbyEby et. al. (2001). Fully et. al. (2001). Fully endoscopicendoscopic vascular decompression of the facial nerve for vascular decompression of the facial nerve for hemifacialhemifacialspasm. spasm. Skull base, 11,Skull base, 11, 189 189 --197.197.FerroliFerroli, P., , P., BroggiBroggi, G. (2005). , G. (2005). Hemifacial spasm due to a Hemifacial spasm due to a subtentorialsubtentorial paramedianparamedian meningiomameningioma..Neurological Sciences, 26,Neurological Sciences, 26, 33--4.4.FreiFrei, K., Truong, D., Dressler, D. (2006). , K., Truong, D., Dressler, D. (2006). BotulinumBotulinum toxin therapy of toxin therapy of hemifacialhemifacial spasm: spasm: Comparing different therapeutic preparations.Comparing different therapeutic preparations. European Journal of Neurology, 13,European Journal of Neurology, 13, 3030--35.35.Fukuda, H., Ishikawa, M., Okumura, R. (2003). Fukuda, H., Ishikawa, M., Okumura, R. (2003). Demonstration of neurovascular compression Demonstration of neurovascular compression in trigeminal neuralgia and in trigeminal neuralgia and hemifacialhemifacial spasm with magnetic resonance imaging: Comparison spasm with magnetic resonance imaging: Comparison with surgical findings in 60 consecutive cases.with surgical findings in 60 consecutive cases. Surgical Neurology, 59,Surgical Neurology, 59, 9393--100.100.HeuserHeuser, K., , K., KertyKerty, E., , E., EideEide, P., , P., CvancarovaCvancarova, M., , M., DietrichsDietrichs, E. (2007). , E. (2007). Microvascular Microvascular decompression for decompression for hemifacialhemifacial spasm: Postoperative spasm: Postoperative neurologicneurologic followfollow--up and evaluation of life up and evaluation of life quality.quality. European Journal of Neurology, 14,European Journal of Neurology, 14, 335335--340.340.Huh, R., Han, I., Moon, J., Chang, J., Chung, S. (2008). Huh, R., Han, I., Moon, J., Chang, J., Chung, S. (2008). Microvascular decompression for Microvascular decompression for hemifacialhemifacial spasm: Analyses of operative complications in 1582 consecutive spasm: Analyses of operative complications in 1582 consecutive patients.patients. Surgical Surgical Neurology, 69,Neurology, 69, 153153--157.157.
References References CtdCtd..Ito, M., Hasegawa, M., Ito, M., Hasegawa, M., HoshidaHoshida, S., Miwa, T., Furukawa, M. (2004). , S., Miwa, T., Furukawa, M. (2004). Successful treatment of Successful treatment of hemifacialhemifacial spasm with selective facial nerve block using doxorubicin (spasm with selective facial nerve block using doxorubicin (adriamycinadriamycin) under local ) under local anesthesia.anesthesia. ActaActa OtoOto--LaryngologicaLaryngologica, 124,, 124, 217217--220.220.KurokawaKurokawa, Y., Maeda, Y., , Y., Maeda, Y., ToyookaToyooka, T., , T., InabaInaba, K. (2004). , K. (2004). Microvascular decompression for Microvascular decompression for hemifacialhemifacial spasm caused by the vertebral artery: A simple and effective trspasm caused by the vertebral artery: A simple and effective transposition method ansposition method using surgical glue.using surgical glue. Surgical Neurology, 61,Surgical Neurology, 61, 398398--404.404.Palacios, E., Palacios, E., ValvassoriValvassori, G. (1999). , G. (1999). Vascular loop and Vascular loop and hemifacialhemifacial spasm.spasm. ENT: Ear, Nose & ENT: Ear, Nose & Throat Journal, 78,Throat Journal, 78, 470470--471.471.Pang, A., Pang, A., O'DayO'Day, J. (2006). , J. (2006). Use of highUse of high--dose dose botulinumbotulinum a toxin in benign essential a toxin in benign essential blepharospasmblepharospasm: Is too high too much?: Is too high too much? Clinical & Experimental Ophthalmology, 34,Clinical & Experimental Ophthalmology, 34, 441441--444.444.Park, J.S., Kong, D.S., Lee, J.A., Park, K. (2008). Hemifacial sPark, J.S., Kong, D.S., Lee, J.A., Park, K. (2008). Hemifacial spasm: Neurovascular compressive pasm: Neurovascular compressive patterns and surgical significance. patterns and surgical significance. ActaActa NeurochirurgicaNeurochirurgica. . 150,150, 235235--241.241.RahmanRahman, E., , E., TrobeTrobe, J., , J., GebarskiGebarski, S. (2002). , S. (2002). Hemifacial spasm caused by vertebral artery Hemifacial spasm caused by vertebral artery dolichoectasiadolichoectasia.. American Journal of Ophthalmology, 133,American Journal of Ophthalmology, 133, 854854--857.857.Tan, E.K, Chan, LL. (2006). Young onset Tan, E.K, Chan, LL. (2006). Young onset hemifacialhemifacial spasm. spasm. ActaActa NeurologicaNeurologica ScandinavicaScandinavica, , 114, 114, 5959--62.62.Tan, N.C, Chan, L.L., Tan E.K. (2002). Hemifacial spasm and invoTan, N.C, Chan, L.L., Tan E.K. (2002). Hemifacial spasm and involuntary facial movements. luntary facial movements. Q Q J MedJ Med, , 9595, 493, 493--500.500.TuncTunc, T., , T., CavdarCavdar, L., , L., KaradagKaradag, Y., , Y., OkuyucaOkuyuca, E., , E., CoskinCoskin, O., , O., InanInan, L. (2008). , L. (2008). Differences in Differences in improvement between patients with idiopathic versus neurovasculaimprovement between patients with idiopathic versus neurovascular r hemifacialhemifacial spasm after spasm after botulinumbotulinum toxin treatment. toxin treatment. Journal of Clinical Neuroscience, 15, Journal of Clinical Neuroscience, 15, 253253--256.256.SauvainSauvain, M.O., , M.O., MagistrisMagistris, M.R., de , M.R., de TriboletTribolet, N. (2001). , N. (2001). Microvascular decompression of the Microvascular decompression of the facial nerve.facial nerve. Operative Techniques in Neurosurgery,4Operative Techniques in Neurosurgery,4, 127, 127--136.136.SindouSindou et. al. (2005). Microvascular decompression for primary et. al. (2005). Microvascular decompression for primary hemifacialhemifacial spasm: Importance spasm: Importance of of intraoperativeintraoperative neurophysiologicalneurophysiological monitoring. monitoring. ActaActa neurochirurgicaneurochirurgica, 147,, 147, 1019 1019 --1026.1026.Ward, A., Ward, A., MolenaersMolenaers, G., , G., ColosimoColosimo, C., , C., BerardelliBerardelli, A. (2006). , A. (2006). Clinical value of Clinical value of botulinumbotulinum toxin toxin in neurological indications.in neurological indications. European Journal of Neurology, 13,European Journal of Neurology, 13, 2020--26.26.
Motor and Sensory Innervation of CN Motor and Sensory Innervation of CN VIIVII
Brachial MotorBrachial Motor: Muscles of : Muscles of facial expression & facial expression & stapediusstapedius
Visceral MotorVisceral Motor: Innervation : Innervation of muscles for tears and salivaof muscles for tears and saliva
Special SensorySpecial Sensory: Taste : Taste anterior 2/3 tongue; hard and anterior 2/3 tongue; hard and soft palatesoft palate
General SensoryGeneral Sensory: : ConchaConcha of of auricle and behind earauricle and behind ear
What are the Treatments for What are the Treatments for Hemifacial Spasm?Hemifacial Spasm?
Archaic treatmentsArchaic treatments
Irrigation of the facial nerveIrrigation of the facial nerve
Injection of toxic compoundsInjection of toxic compounds
Removal of the Removal of the orbicularisorbicularisoculioculi
EbyEby et al. (2001), Tan et al. (2002)et al. (2001), Tan et al. (2002)
Assessment of Intelligibility of Assessment of Intelligibility of DysarthricDysarthric Speech (AIDS) Speech (AIDS) CtdCtd..
2 month 2 month prepre--opop
1 week 1 week postpost--opop
1 month 1 month postpost--opop
5 month 5 month postpost--opop
Word Level Word Level IntelligibilityIntelligibility
67%67% 73%73% 76%76% 71%*71%*
Sentence Sentence Level Level
IntelligibilityIntelligibility
70%70% 95.5%95.5% 99.5%99.5% 100%100%